Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.72% |
| Q3 2025 | 10.90% |
| Q2 2025 | 22.03% |
| Q1 2025 | -40.47% |
| Q4 2024 | 14.34% |
| Q3 2024 | -7.15% |
| Q2 2024 | 11.04% |
| Q1 2024 | 0.25% |
| Q4 2023 | -2.11% |
| Q3 2023 | -1.28% |
| Q2 2023 | 14.16% |
| Q1 2023 | -6.91% |
| Q4 2022 | 19.93% |
| Q3 2022 | -1.97% |
| Q2 2022 | -6.53% |
| Q1 2022 | 6.13% |
| Q4 2021 | 3.29% |
| Q3 2021 | 2.08% |
| Q2 2021 | 64.68% |
| Q1 2021 | -3.28% |
| Q4 2020 | 22.91% |
| Q3 2020 | 278.12% |
| Q2 2020 | -19.83% |
| Q1 2020 | 26.32% |
| Q4 2019 | 6060.87% |
| Q3 2019 | -76.53% |
| Q2 2019 | -73.08% |
| Q1 2019 | -5.94% |
| Q4 2018 | 1.04% |
| Q3 2018 | -22.63% |
| Q2 2018 | 90.38% |
| Q1 2018 | -30.48% |
| Q4 2017 | -6.03% |
| Q3 2017 | 19.16% |
| Q2 2017 | -7.22% |
| Q1 2017 | -6.25% |
| Q4 2016 | 5.21% |
| Q3 2016 | 8.63% |
| Q2 2016 | -6.41% |
| Q1 2016 | 4.36% |